Wellington Management Group LLP 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-10-09 1:53 pm Sale | 2020-09-30 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Wellington Management Group LLP | 0 0.000% | -1,343,168 (Position Closed) | Filing |
| 2020-08-10 09:43 am Sale | 2020-07-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Wellington Management Group LLP | 1,343,168 7.720% | -998,043 (-42.63%) | Filing |